CAPA, which stands for Corrective and Preventive Action, is a systematic approach used in clinical research and other regulated industries to address and resolve quality issues. It involves identifying the root cause of a problem, implementing corrective measures to fix the immediate issue, and taking preventive steps to ensure the problem does not recur in the future.
The CAPA process is an essential component of quality management systems and is often required by regulatory agencies such as the FDA. It helps organizations maintain compliance, improve processes, and enhance overall quality by addressing both existing problems and potential risks proactively.
CAPA is crucial in clinical research as it ensures the integrity and reliability of study data and processes. By systematically addressing issues and preventing their recurrence, CAPA helps maintain compliance with Good Clinical Practice (GCP) guidelines and regulatory requirements, which is essential for the validity of clinical trials.
Furthermore, CAPA contributes to continuous improvement in clinical research operations. It promotes a culture of quality and accountability, leading to more efficient processes, reduced errors, and ultimately, safer and more effective clinical trials that can benefit patients and advance medical knowledge.
Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…
The Axcellant team recently attended the International Conference on Nuclear Cardiology (ICNC) in Berlin – one of the most important…
Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…
Copyright @ 2026 Axcellant